8
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T0287 | Hexamethonium Bromide | Gangliostat,Simpatoblock,Hexamethonium Dibromide | Apoptosis , Dopamine Receptor , AChR |
Hexamethonium Bromide (Hexamethonium Dibromide), a specific antagonist of neuronal-type nicotinic AChR in ganglia, is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. | |||
T69939 | Hexamethonium tartrate | ||
Hexamethonium tartrate is a nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It ... | |||
T69023 | Hexamethonium chloride | ||
Hexamethonium chloride is a preferential nicotinic receptor blocker at the level of autonomic ganglia. It has been shown to cross the blood-brain barrier only in high doses. | |||
T70269 | Hexamethonium chloride dihydrate | ||
Hexamethonium chloride dihydrate is a non-depolarizing NMJ blocker and nAChR antagonist. It has previously been used to treat hypertension. It inhibits sympathetic nervous system activity and acts as a skeletal muscle re... | |||
T69022 | Hexamethonium Free Base | ||
Hexamethonium Free Base is a nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It... | |||
T68645 | Hexamethonium monotartrate | ||
Hexamethonium monotartrate is a non-depolarizing NMJ blocker and nAChR antagonist. It has previously been used to treat hypertension. It inhibits sympathetic nervous system activity and acts as a skeletal muscle relaxant... | |||
T69161 | Hexamethonium bromide dihydrate | ||
Hexamethonium bromide dihydrate is a non-depolarizing NMJ blocker and nAChR antagonist. It has previously been used to treat hypertension. It inhibits sympathetic nervous system activity and acts as a skeletal muscle rel... | |||
T69938 | Befiradol fumarate | ||
Befiradol fumarate is a highly selective and potent 5-HT1A receptor agonist potentially for the treatment of drug-induced dyskinesia in patients with Parkinson's disease. |